WHO Approves Bavarian Nordic’s Mpox Vaccine for Adolescents
The World Health Organization (WHO) has approved Bavarian Nordic’s mpox vaccine, Jynneos, for adolescents aged 12 to 17. This age group is considered especially vulnerable […]
The World Health Organization (WHO) has approved Bavarian Nordic’s mpox vaccine, Jynneos, for adolescents aged 12 to 17. This age group is considered especially vulnerable […]
The World Health Organization (WHO) has added the MVA-BN vaccine to its prequalification list as the first approved vaccine for mpox. This prequalification aims to […]
Fabry Disease and Its Impact on Visual Acuity A recent study has shed light on the connection between Fabry disease and potential eye-related abnormalities, suggesting […]
Early Screening for LOPD Crucial for Diagnosis Recent research highlights the importance of early screening for Limb-Onset Pompe Disease (LOPD). Identifying individuals with unexplained muscle […]
Darmiyan Inc. Receives FDA Approval for Brain Health Technology Darmiyan, Inc., a prominent innovator in brain health technology, has announced a significant milestone. The U.S. […]
Dermatology Highlights: A Look Back at May’s Top Stories May was a busy month in the world of dermatology, with several key developments and stories […]
New Hope for Alzheimer’s: The Role of Hevin in Preventing Cognitive Decline Alzheimer’s disease and other forms of dementia pose a significant global health challenge. […]
MIT Uncovers the Impact of High-Fat Diets on Insulin Resistance A new study from MIT sheds light on how consuming a diet high in fat […]